Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pituitary disorders during pregnancy

D Prager1, G D Braunstein

  • 1Department of Medicine, Cedars-Sinai Medical Center-University of California at Los Angeles School of Medicine, USA.

Endocrinology and Metabolism Clinics of North America
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo.

Oncology letters·2012
Same author

Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells.

British journal of cancer·2008
Same author

Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.

Rheumatology (Oxford, England)·2008
Same author

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

The Journal of clinical endocrinology and metabolism·2003
Same author

Treatment of gynecomastia.

Current opinion in investigational drugs (London, England : 2000)·2001
Same author

Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma.

Thyroid : official journal of the American Thyroid Association·2001
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Pregnancy induces hormonal shifts affecting pituitary tumors, potentially causing growth. Management involves medications like bromocryptine and dDAVP, or surgery for severe complications, ensuring maternal and fetal health.

Area of Science:

  • Endocrinology
  • Obstetrics
  • Reproductive Medicine

Background:

  • Pregnancy involves significant morphologic and physiologic changes, including altered pituitary hormone levels.
  • Hormonal fluctuations during pregnancy can impact pre-existing pituitary tumors, such as prolactinomas and GH-secreting tumors.

Purpose of the Study:

  • To review the impact of pregnancy on various pituitary tumors and related conditions.
  • To outline management strategies for pituitary abnormalities during pregnancy.

Main Methods:

  • Literature review of pituitary disorders in pregnancy.
  • Analysis of hormonal changes and tumor behavior during gestation.

Main Results:

  • Pregnancy can exacerbate prolactinomas and GH-secreting tumors, requiring medical or surgical intervention.

Related Experiment Videos

  • Hypopituitarism and diabetes insipidus are critical conditions needing prompt diagnosis and treatment.
  • Bromocryptine, octreotide, and dDAVP are key therapeutic agents.

    • Conclusions:

    • Careful monitoring and timely intervention are crucial for managing pituitary tumors and related disorders in pregnant patients.
    • Hormonal replacement and neurosurgical decompression are vital for severe cases to prevent mortality.